研究报告 |
|
|
|
|
OPCML在胃癌中的表达及对胃癌细胞生物学的作用 |
李明1, 王永飞1, 焦金霞1, 杨洋1, 张宁3, 邢象斌2, 马三梅1 |
1. 暨南大学生物工程学系 广州 510632;
2. 中山大学附属第一医院 广州 510080;
3. 广州医科大学附属第一医院 广州 510120 |
|
The Expression of OPCML in Gastric Cancer and Role of OPCML in Biological Function of Gastric Cancer Cell |
LI Ming1, WANG Yong-fei1, JIAO Jin-xia1, YANG Yang1, ZHANG Ning3, XING Xiang-bin2, MA San-mei1 |
1. Department of Biotechnology, Jinan University, Guangzhou 510632, China;
2. Department of Gastroenterology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China;
3. First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510120, China |
引用本文:
李明, 王永飞, 焦金霞, 杨洋, 张宁, 邢象斌, 马三梅. OPCML在胃癌中的表达及对胃癌细胞生物学的作用[J]. 中国生物工程杂志, 2015, 35(2): 1-7.
LI Ming, WANG Yong-fei, JIAO Jin-xia, YANG Yang, ZHANG Ning, XING Xiang-bin, MA San-mei. The Expression of OPCML in Gastric Cancer and Role of OPCML in Biological Function of Gastric Cancer Cell. China Biotechnology, 2015, 35(2): 1-7.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20150201
或
https://manu60.magtech.com.cn/biotech/CN/Y2015/V35/I2/1
|
[1] 徐飚, 王建明. 胃癌流行病学研究. 中华肿瘤防治杂志, 2006, 13(1): 1-7. Xu B, Wang J M. Epidemiological study of gastric cancer. Chinese Journal of Cancer Prevention and Treatment, 2006, 13(1):1-7.
[2] Jemal A, Bray F, Center M M, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61: 69-90.
[3] Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127: 2893-2917.
[4] Han-Shao Liu, Hua-Sheng Xiao. MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol, 2014, 20(34):12007-12017.
[5] Hartgrink H H, Van de Velde C J. Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer. J Surg Oncol, 2005, 90(3): 153-165.
[6] Schofield P R, McFarland K C, Hayflick J S, et al. Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact. The EMBO Journal, 1989, 8:489-495.
[7] 覃宇翔, 姚德生. OPCML基因与肿瘤关系的研究进展. 广西医科大学学报, 2011, 28 (3): 490-492. Jia Y X, Yao D S. Study on the relationship between OPCML gene and tumor. Journal of Guangxi Medical University, 2011, 28 (3): 490-492.
[8] Zhou F, Ma M, Tao G, et al. Detection of circulating methylated opioid binding protein/cell adhesion molecule-like gene as a biomarker for ovarian carcinoma. ClinLab, 2014, 60(5): 759-765.
[9] Duarte-Pereira S, Paiva F, Costa V L, et al. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma. Eur J Cancer, 2011, 47(7): 1106-1114.
[10] Ye F, Zhang S F, Xie X, et al. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma. Cancer Invest, 2008, 26(6): 569-574.
[11] Reed J E, Dunn J R, du Plessis D G, et al. Expression of cellular adhesion molecule ‘OPCML’ is down-regulated in gliomas and other brain tumours. Neuropathol Appl Neurobiol, 2007, 33(1): 77-85.
[12] 张宁, 许继德, 元刚,等. 启动子甲基化致 OPCML 基因失活在胃癌发病中的作用. 广东医学, 2012, 33 (16): 2367-2371. Zhang N, Xu J D, Yuan G, et al. Promoter methylation-induced OPCML expression silence in progression of gastric cancer. Guangdong Medical Journal, 2012, 33 (16): 2367-2371.
[13] 李金平, 王昇, 李宏,等. 候选抑癌基因 OPCML 在人乳腺癌中的表达及其临床意义. 第三军医大学学报, 2013, 35(23): 2565-2568. Li J P, Wang S, Li H, et al. Expression and clinical significances of candidate tumor suppressor gene OPCML in human breast cancer tissues. Journal of Third Military Medical University, 2013, 35(23): 2565-2568.
[14] Meng F, Li H, Shi H, et al. MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway. PLoS One, 2013, 8(4): e60821.
[15] Xu L, Li X, Chu E S, et al. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival. Gut, 2012, 61(7):977-985.
[16] Dhar D K, Udagawa J, Ishihara S, et al. Expression of regeneration gene I in gastric adenocarcinomas:correlation with tumor differentiation status and patient survival. Cancer, 2004, 100(6): 1130-1136.
[17] McKie A B, Vaughan S, Zanini E, et al. The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer. Cancer Discov, 2012, 2(2): 156-171.
[18] 童红洲, 胡宾, 沈敬华. OPCML蛋白在上皮性卵巢癌中的表达及意义. 内蒙古医科大学学报, 2013, 35(2): 142-145. Tong H Z, Hu B, Shen J H. The expression and significance of OPCML protein in primary epithelial ovarian cancer. Journal of Inner Mongolia Medical University, 2013, 35(2): 142-145.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|